CTGF: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
imported>Knox490
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''CTGF''', also known as '''CCN2''' or '''connective tissue growth factor''',<ref name="Jun_Lau_2011">{{cite journal | vauthors = Jun JI, Lau LF | title = Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets | journal = Nat Rev Drug Discov | volume = 10 | issue = 12 | pages = 945–63 |date=December 2011 | pmid = 22129992 | doi = 10.1038/nrd3599 | pmc = 3663145 }}</ref><ref name="Hall-Glenn_2011">{{cite journal | vauthors = Hall-Glenn F, Lyons KM | title = Roles for CCN2 in normal physiological processes | journal = Cell. Mol. Life Sci. | volume = 68 | issue = 19 | pages = 3209–17 |date=October 2011 | pmid = 21858450 | doi = 10.1007/s00018-011-0782-7 | url = | pmc = 3670951 }}</ref> is a [[matricellular protein]] of the CCN family of [[extracellular matrix]]-associated [[heparin]]-binding proteins (see also [[CCN intercellular signaling protein]]).<ref name="pmid18775791">{{cite journal | vauthors = Chen CC, Lau LF | title = Functions and mechanisms of action of CCN matricellular proteins | journal = Int. J. Biochem. Cell Biol. | volume = 41 | issue = 4 | pages = 771–83 |date=April 2009 | pmid = 18775791 | pmc = 2668982 | doi = 10.1016/j.biocel.2008.07.025 }}</ref><ref name="pmid18789696">{{cite journal | vauthors = Holbourn KP, Acharya KR, Perbal B | title = The CCN family of proteins: structure-function relationships | journal = Trends Biochem. Sci. | volume = 33 | issue = 10 | pages = 461–73 |date=October 2008 | pmid = 18789696 | pmc = 2683937 | doi = 10.1016/j.tibs.2008.07.006 }}</ref><ref name="pmid17130294">{{cite journal | vauthors = Leask A, Abraham DJ | title = All in the CCN family: essential matricellular signaling modulators emerge from the bunker | journal = J. Cell Sci. | volume = 119 | issue = Pt 23 | pages = 4803–10 |date=December 2006 | pmid = 17130294 | doi = 10.1242/jcs.03270 }}</ref> CTGF has important roles in many biological processes, including [[cell adhesion]], [[cell migration|migration]], [[cell growth|proliferation]], [[angiogenesis]], skeletal development, and tissue wound repair, and is critically involved in fibrotic disease and several forms of [[cancer]]s.<ref name="Jun_Lau_2011"/><ref name="Hall-Glenn_2011"/><ref name="pmid21484188">{{cite journal | vauthors = Kubota S, Takigawa M | title = The role of CCN2 in cartilage and bone development | journal = J Cell Commun Signal | volume = 5 | issue = 3 | pages = 209–17 |date=August 2011 | pmid = 21484188 | pmc = 3145877 | doi = 10.1007/s12079-011-0123-5 }}</ref>
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}


<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
== Structure and binding partners ==
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Connective tissue growth factor
| HGNCid = 2500
| Symbol = CTGF
| AltSymbols =; CCN2; HCS24; IGFBP8; MGC102839; NOV2
| OMIM = 121009
| ECnumber = 
| Homologene = 1431
| MGIid = 95537
| GeneAtlas_image1 = PBB_GE_CTGF_209101_at_tn.png
| Function = {{GNF_GO|id=GO:0005178 |text = integrin binding}} {{GNF_GO|id=GO:0005515 |text = protein binding}} {{GNF_GO|id=GO:0005520 |text = insulin-like growth factor binding}} {{GNF_GO|id=GO:0008201 |text = heparin binding}}
| Component = {{GNF_GO|id=GO:0005576 |text = extracellular region}} {{GNF_GO|id=GO:0005578 |text = proteinaceous extracellular matrix}} {{GNF_GO|id=GO:0005615 |text = extracellular space}} {{GNF_GO|id=GO:0005625 |text = soluble fraction}} {{GNF_GO|id=GO:0005886 |text = plasma membrane}}
| Process = {{GNF_GO|id=GO:0001502 |text = cartilage condensation}} {{GNF_GO|id=GO:0001503 |text = ossification}} {{GNF_GO|id=GO:0001525 |text = angiogenesis}} {{GNF_GO|id=GO:0001558 |text = regulation of cell growth}} {{GNF_GO|id=GO:0006260 |text = DNA replication}} {{GNF_GO|id=GO:0007155 |text = cell adhesion}} {{GNF_GO|id=GO:0007160 |text = cell-matrix adhesion}} {{GNF_GO|id=GO:0007229 |text = integrin-mediated signaling pathway}} {{GNF_GO|id=GO:0008543 |text = fibroblast growth factor receptor signaling pathway}} {{GNF_GO|id=GO:0008544 |text = epidermis development}} {{GNF_GO|id=GO:0009611 |text = response to wounding}} {{GNF_GO|id=GO:0016477 |text = cell migration}} {{GNF_GO|id=GO:0030154 |text = cell differentiation}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 1490
    | Hs_Ensembl = ENSG00000118523
    | Hs_RefseqProtein = NP_001892
    | Hs_RefseqmRNA = NM_001901
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = 6
    | Hs_GenLoc_start = 132311009
    | Hs_GenLoc_end = 132314206
    | Hs_Uniprot = P29279
    | Mm_EntrezGene = 14219
    | Mm_Ensembl = ENSMUSG00000019997
    | Mm_RefseqmRNA = NM_010217
    | Mm_RefseqProtein = NP_034347
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 10
    | Mm_GenLoc_start = 24284923
    | Mm_GenLoc_end = 24288096
    | Mm_Uniprot = Q91V29
  }}
}}
'''CTGF''' (connective tissue [[growth factor]]) is a [[cysteine]]-rich, [[matrix (biology)|matrix]]-associated, [[heparin]]-binding [[protein]]. [[In vitro]], CTGF mirrors some of the effects of [[TGF beta]] on [[skin]] [[fibroblasts]], such as stimulation of [[extracellular matrix]] production, [[chemotaxis]], [[proliferation]] and [[integrin]] expression. CTGF can promote [[endothelial cell]] growth, migration, adhesion and survival and is thus implicated in endothelial cell function and [[angiogenesis]]<ref>Brigstock DR (2002) Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5:153-165.</ref>. <br /><br />


CTGF binds to [[perlecan]]<ref>Nishida T et al. (2003) CTGF/Hcs24, hypertrophic chondrocyte-specific gene product, interacts with perlecan in regulating the proliferation and differentiation of chondrocytes. J Cell Physiol 196:265-275.</ref>, a [[proteoglycan]] which has been localised in [[synovium]], [[cartilage]] and numerous other tissues. <br /><br />
Members of the CCN protein family, including CTGF, are structurally characterized by having four conserved, [[cysteine]]-rich domains. These domains are, from N- to C-termini, the insulin-like growth factor binding protein ([[insulin-like growth factor-binding protein|IGFBP]]) domain, the von Willebrand type C repeats ([[Von Willebrand factor type C domain|vWC]]) domain, the thrombospondin type 1 repeat (TSR) domain, and a C-terminal domain (CT) with a [[cysteine knot]] motif. CTGF exerts its functions by binding to various cell surface receptors in a context-dependent manner, including [[integrin receptor]]s,<ref name="pmid10082563">{{cite journal | vauthors = Babic AM, Chen CC, Lau LF | title = Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin α<sub>v</sub>β<sub>3</sub>, promotes endothelial cell survival, and induces angiogenesis in vivo | journal = Mol. Cell. Biol. | volume = 19 | issue = 4 | pages = 2958–66 |date=April 1999 | pmid = 10082563 | pmc = 84090 | doi = }}</ref><ref name="pmid10446209">{{cite journal | vauthors = Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC | title = Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin α<sub>IIb</sub>β<sub>3</sub> | journal = J. Biol. Chem. | volume = 274 | issue = 34 | pages = 24321–7 |date=August 1999 | pmid = 10446209 | doi =10.1074/jbc.274.34.24321 }}</ref><ref name="pmid12036876">{{cite journal | vauthors = Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SC | title = Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions | journal = Blood | volume = 99 | issue = 12 | pages = 4457–65 |date=June 2002 | pmid = 12036876 | doi =10.1182/blood.V99.12.4457 }}</ref> cell surface  [[Heparan sulfate#Proteoglycans|heparan sulfate proteoglycans]] (HSPGs),<ref name="pmid14684735">{{cite journal | vauthors = Gao R, Brigstock DR | title = Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin α(v)β(3) and heparan sulfate proteoglycan | journal = J. Biol. Chem. | volume = 279 | issue = 10 | pages = 8848–55 |date=March 2004 | pmid = 14684735 | doi = 10.1074/jbc.M313204200 }}</ref> [[low density lipoprotein receptor|LRP]]s,<ref name="pmid11518710">{{cite journal | vauthors = Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR, Carmichael DF | title = The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor | journal = J. Biol. Chem. | volume = 276 | issue = 44 | pages = 40659–67 |date=November 2001 | pmid = 11518710 | doi = 10.1074/jbc.M105180200 }}</ref> and TrkA.<ref name="pmid15601748">{{cite journal | vauthors = Wahab NA, Weston BS, Mason RM | title = Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA | journal = J. Am. Soc. Nephrol. | volume = 16 | issue = 2 | pages = 340–51 |date=February 2005 | pmid = 15601748 | doi = 10.1681/ASN.2003100905 }}</ref> In addition, CTGF also binds growth factors and extracellular matrix proteins. The N-terminal half of CTGF interacts with [[aggrecan]],<ref name="pmid19298220">{{cite journal | vauthors = Aoyama E, Hattori T, Hoshijima M, Araki D, Nishida T, Kubota S, Takigawa M | title = N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan | journal = Biochem. J. | volume = 420 | issue = 3 | pages = 413–20 |date=June 2009 | pmid = 19298220 | doi = 10.1042/BJ20081991 }}</ref> the TSR domain interacts with [[VEGF]],<ref name="pmid12114504">{{cite journal | vauthors = Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y | title = Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165 | journal = J. Biol. Chem. | volume = 277 | issue = 39 | pages = 36288–95 |date=September 2002 | pmid = 12114504 | doi = 10.1074/jbc.M201674200 }}</ref> and the CT domain interacts with members of the TGF-β superfamily, [[fibronectin]], [[perlecan]], [[fibulin-1]], [[slit (gene)|slit]], and [[mucin]]s.<ref name="Jun_Lau_2011"/><ref name="Hall-Glenn_2011"/>


CTGF has been implicated in [[extracellular matrix]] remodelling in [[wound healing]], [[scleroderma]] and other fibrotic processes, as it is capable of upregulating both [[matrix metalloproteinases]] (MMPs) and their inhibitors ([[TIMPs]]).  Therefore, CTGF has the potential to activate both the synthesis and degradation of the [[extracellular matrix]].
== Role in development ==


[[Knockout mice]] which have had the [[gene]] for CTGF removed do not develop normally. Impaired [[chondrocyte]] proliferation, [[angiogenesis]], [[extracellular matrix]] production and turnover leads to abnormal skeletal growth.<ref>Ivkovic S et al. (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal deveopment Development 130:2779-2791.</ref>  
Knockout mice with the Ctgf gene disrupted die at birth due to respiratory stress as a result of severe [[chondrodysplasia]].<ref name="pmid12736220">{{cite journal | vauthors = Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM | title = Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development | journal = Development | volume = 130 | issue = 12 | pages = 2779–91 |date=June 2003 | pmid = 12736220 | pmc = 3360973 | doi =10.1242/dev.00505 }}</ref> Ctgf-null mice also show defects in angiogenesis, with impaired interaction between endothelial cells and pericytes and collagen IV deficiency in the endothelial basement membrane.<ref name="pmid22363445">{{cite journal | vauthors = Hall-Glenn F, De Young RA, Huang BL, van Handel B, Hofmann JJ, Chen TT, Choi A, Ong JR, Benya PD, Mikkola H, Iruela-Arispe ML, Lyons KM | title = CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis | journal = PLoS ONE | volume = 7 | issue = 2 | pages = e30562 | year = 2012 | pmid = 22363445 | pmc = 3282727 | doi = 10.1371/journal.pone.0030562 }}</ref> CTGF is also important for [[pancreatic beta cell]] development,<ref name="pmid19131512">{{cite journal | vauthors = Crawford LA, Guney MA, Oh YA, Deyoung RA, Valenzuela DM, Murphy AJ, Yancopoulos GD, Lyons KM, Brigstock DR, Economides A, Gannon M | title = Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and beta-cell proliferation during embryogenesis | journal = Mol. Endocrinol. | volume = 23 | issue = 3 | pages = 324–36 |date=March 2009 | pmid = 19131512 | pmc = 2654514 | doi = 10.1210/me.2008-0045 }}</ref> and is critical for normal [[ovarian follicle]] development and [[ovulation]].<ref name="pmid21868453">{{cite journal | vauthors = Nagashima T, Kim J, Li Q, Lydon JP, DeMayo FJ, Lyons KM, Matzuk MM | title = Connective tissue growth factor is required for normal follicle development and ovulation | journal = Mol. Endocrinol. | volume = 25 | issue = 10 | pages = 1740–59 |date=October 2011 | pmid = 21868453 | doi = 10.1210/me.2011-1045 | pmc = 3182424 }}</ref>
 
== Clinical significance ==
 
CTGF is associated with [[wound healing]] and virtually all [[fibrotic]] pathology.<ref name="pmid17130294" /><ref name="Brigstock_2010">{{cite journal | author = Brigstock DR | title = Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals | journal = J Cell Commun Signal | volume = 4 | issue = 1 | pages = 1–4 |date=March 2010 | pmid = 19798591 | pmc = 2821473 | doi = 10.1007/s12079-009-0071-5 }}</ref> It is thought that CTGF can cooperate with [[TGF-β]] to induce sustained [[fibrosis]]<ref name="pmid10457363">{{cite journal | vauthors = Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K | title = Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model | journal = J. Cell. Physiol. | volume = 181 | issue = 1 | pages = 153–9 |date=October 1999 | pmid = 10457363 | doi = 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K }}</ref> and to exacerbate extracellular matrix production in association other fibrosis-inducing conditions.<ref name="Brigstock_2010"/> Overexpression of CTGF in fibroblasts promotes fibrosis in the dermis, kidney, and lung,<ref name="pmid20213804">{{cite journal | vauthors = Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, Nakamura H, Leask A, Abraham D, Bou-Gharios G, de Crombrugghe B | title = Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis | journal = Arthritis Rheum. | volume = 62 | issue = 5 | pages = 1523–32 |date=May 2010 | pmid = 20213804 | doi = 10.1002/art.27382 | pmc = 3866029 }}</ref> and deletion of Ctgf in fibroblasts and smooth muscle cells greatly reduces [[bleomycin]]-induced skin fibrosis.<ref name="pmid20936632">{{cite journal | vauthors = Liu S, Shi-wen X, Abraham DJ, Leask A | title = CCN2 is required for bleomycin-induced skin fibrosis in mice | journal = Arthritis Rheum. | volume = 63 | issue = 1 | pages = 239–46 |date=January 2011 | pmid = 20936632 | doi = 10.1002/art.30074 }}</ref>
 
In addition to fibrosis, aberrant CTGF expression is also associated with many types of malignancies, [[diabetic nephropathy]]<ref>{{cite journal |vauthors=Ellina O, Chatzigeorgiou A, Kouyanou S |title=Extracellular matrix-associated (GAGs, CTGF), angiogenic (VEGF) and inflammatory factors (MCP-1, CD40, IFN-γ) in type 1 diabetes mellitus nephropathy |journal=Clin. Chem. Lab. Med. |volume=50 |issue=1 |pages=167–74 |date=January 2012 |pmid=22505539 |doi=10.1515/cclm.2011.881 |url=|display-authors=etal}}</ref> and [[retinopathy]], arthritis, and cardiovascular diseases. Several clinical trials are now ongoing that investigate the therapeutic value of targeting CTGF in fibrosis, diabetic nephropathy, and [[pancreatic cancer]].<ref name="Jun_Lau_2011"/>
 
==See also==
*[[Ctgf/hcs24 CAESAR]]
*[[CYR61]] (CCN1)
{{Clear}}


==References==
==References==
{{reflist|2}}
{{reflist|35em}}
 
==External links==
* {{UCSC gene info|CTGF}}


==Further reading==
{{Growth factor receptor modulators}}
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal  | author=Brigstock DR |title=The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. |journal=Endocr. Rev. |volume=20 |issue= 2 |pages= 189-206 |year= 1999 |pmid= 10204117 |doi=  }}
*{{cite journal  | author=Abdel Wahab N, Mason RM |title=Connective tissue growth factor and renal diseases: some answers, more questions. |journal=Curr. Opin. Nephrol. Hypertens. |volume=13 |issue= 1 |pages= 53-8 |year= 2004 |pmid= 15090860 |doi=  }}
*{{cite journal  | author=Leask A |title=Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis. |journal=The Keio journal of medicine |volume=53 |issue= 2 |pages= 74-7 |year= 2004 |pmid= 15247510 |doi=  }}
}}
{{refend}}


[[Category:Growth factors]]
[[Category:Growth factors]]
{{WikiDoc Sources}}
[[Category:CCN proteins]]

Latest revision as of 00:26, 13 July 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

CTGF, also known as CCN2 or connective tissue growth factor,[1][2] is a matricellular protein of the CCN family of extracellular matrix-associated heparin-binding proteins (see also CCN intercellular signaling protein).[3][4][5] CTGF has important roles in many biological processes, including cell adhesion, migration, proliferation, angiogenesis, skeletal development, and tissue wound repair, and is critically involved in fibrotic disease and several forms of cancers.[1][2][6]

Structure and binding partners

Members of the CCN protein family, including CTGF, are structurally characterized by having four conserved, cysteine-rich domains. These domains are, from N- to C-termini, the insulin-like growth factor binding protein (IGFBP) domain, the von Willebrand type C repeats (vWC) domain, the thrombospondin type 1 repeat (TSR) domain, and a C-terminal domain (CT) with a cysteine knot motif. CTGF exerts its functions by binding to various cell surface receptors in a context-dependent manner, including integrin receptors,[7][8][9] cell surface heparan sulfate proteoglycans (HSPGs),[10] LRPs,[11] and TrkA.[12] In addition, CTGF also binds growth factors and extracellular matrix proteins. The N-terminal half of CTGF interacts with aggrecan,[13] the TSR domain interacts with VEGF,[14] and the CT domain interacts with members of the TGF-β superfamily, fibronectin, perlecan, fibulin-1, slit, and mucins.[1][2]

Role in development

Knockout mice with the Ctgf gene disrupted die at birth due to respiratory stress as a result of severe chondrodysplasia.[15] Ctgf-null mice also show defects in angiogenesis, with impaired interaction between endothelial cells and pericytes and collagen IV deficiency in the endothelial basement membrane.[16] CTGF is also important for pancreatic beta cell development,[17] and is critical for normal ovarian follicle development and ovulation.[18]

Clinical significance

CTGF is associated with wound healing and virtually all fibrotic pathology.[5][19] It is thought that CTGF can cooperate with TGF-β to induce sustained fibrosis[20] and to exacerbate extracellular matrix production in association other fibrosis-inducing conditions.[19] Overexpression of CTGF in fibroblasts promotes fibrosis in the dermis, kidney, and lung,[21] and deletion of Ctgf in fibroblasts and smooth muscle cells greatly reduces bleomycin-induced skin fibrosis.[22]

In addition to fibrosis, aberrant CTGF expression is also associated with many types of malignancies, diabetic nephropathy[23] and retinopathy, arthritis, and cardiovascular diseases. Several clinical trials are now ongoing that investigate the therapeutic value of targeting CTGF in fibrosis, diabetic nephropathy, and pancreatic cancer.[1]

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 Jun JI, Lau LF (December 2011). "Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets". Nat Rev Drug Discov. 10 (12): 945–63. doi:10.1038/nrd3599. PMC 3663145. PMID 22129992.
  2. ↑ 2.0 2.1 2.2 Hall-Glenn F, Lyons KM (October 2011). "Roles for CCN2 in normal physiological processes". Cell. Mol. Life Sci. 68 (19): 3209–17. doi:10.1007/s00018-011-0782-7. PMC 3670951. PMID 21858450.
  3. ↑ Chen CC, Lau LF (April 2009). "Functions and mechanisms of action of CCN matricellular proteins". Int. J. Biochem. Cell Biol. 41 (4): 771–83. doi:10.1016/j.biocel.2008.07.025. PMC 2668982. PMID 18775791.
  4. ↑ Holbourn KP, Acharya KR, Perbal B (October 2008). "The CCN family of proteins: structure-function relationships". Trends Biochem. Sci. 33 (10): 461–73. doi:10.1016/j.tibs.2008.07.006. PMC 2683937. PMID 18789696.
  5. ↑ 5.0 5.1 Leask A, Abraham DJ (December 2006). "All in the CCN family: essential matricellular signaling modulators emerge from the bunker". J. Cell Sci. 119 (Pt 23): 4803–10. doi:10.1242/jcs.03270. PMID 17130294.
  6. ↑ Kubota S, Takigawa M (August 2011). "The role of CCN2 in cartilage and bone development". J Cell Commun Signal. 5 (3): 209–17. doi:10.1007/s12079-011-0123-5. PMC 3145877. PMID 21484188.
  7. ↑ Babic AM, Chen CC, Lau LF (April 1999). "Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin αvβ3, promotes endothelial cell survival, and induces angiogenesis in vivo". Mol. Cell. Biol. 19 (4): 2958–66. PMC 84090. PMID 10082563.
  8. ↑ Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC (August 1999). "Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin αIIbβ3". J. Biol. Chem. 274 (34): 24321–7. doi:10.1074/jbc.274.34.24321. PMID 10446209.
  9. ↑ Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SC (June 2002). "Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions". Blood. 99 (12): 4457–65. doi:10.1182/blood.V99.12.4457. PMID 12036876.
  10. ↑ Gao R, Brigstock DR (March 2004). "Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin α(v)β(3) and heparan sulfate proteoglycan". J. Biol. Chem. 279 (10): 8848–55. doi:10.1074/jbc.M313204200. PMID 14684735.
  11. ↑ Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR, Carmichael DF (November 2001). "The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor". J. Biol. Chem. 276 (44): 40659–67. doi:10.1074/jbc.M105180200. PMID 11518710.
  12. ↑ Wahab NA, Weston BS, Mason RM (February 2005). "Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA". J. Am. Soc. Nephrol. 16 (2): 340–51. doi:10.1681/ASN.2003100905. PMID 15601748.
  13. ↑ Aoyama E, Hattori T, Hoshijima M, Araki D, Nishida T, Kubota S, Takigawa M (June 2009). "N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan". Biochem. J. 420 (3): 413–20. doi:10.1042/BJ20081991. PMID 19298220.
  14. ↑ Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y (September 2002). "Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165". J. Biol. Chem. 277 (39): 36288–95. doi:10.1074/jbc.M201674200. PMID 12114504.
  15. ↑ Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM (June 2003). "Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development". Development. 130 (12): 2779–91. doi:10.1242/dev.00505. PMC 3360973. PMID 12736220.
  16. ↑ Hall-Glenn F, De Young RA, Huang BL, van Handel B, Hofmann JJ, Chen TT, Choi A, Ong JR, Benya PD, Mikkola H, Iruela-Arispe ML, Lyons KM (2012). "CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis". PLoS ONE. 7 (2): e30562. doi:10.1371/journal.pone.0030562. PMC 3282727. PMID 22363445.
  17. ↑ Crawford LA, Guney MA, Oh YA, Deyoung RA, Valenzuela DM, Murphy AJ, Yancopoulos GD, Lyons KM, Brigstock DR, Economides A, Gannon M (March 2009). "Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and beta-cell proliferation during embryogenesis". Mol. Endocrinol. 23 (3): 324–36. doi:10.1210/me.2008-0045. PMC 2654514. PMID 19131512.
  18. ↑ Nagashima T, Kim J, Li Q, Lydon JP, DeMayo FJ, Lyons KM, Matzuk MM (October 2011). "Connective tissue growth factor is required for normal follicle development and ovulation". Mol. Endocrinol. 25 (10): 1740–59. doi:10.1210/me.2011-1045. PMC 3182424. PMID 21868453.
  19. ↑ 19.0 19.1 Brigstock DR (March 2010). "Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals". J Cell Commun Signal. 4 (1): 1–4. doi:10.1007/s12079-009-0071-5. PMC 2821473. PMID 19798591.
  20. ↑ Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K (October 1999). "Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model". J. Cell. Physiol. 181 (1): 153–9. doi:10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K. PMID 10457363.
  21. ↑ Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, Nakamura H, Leask A, Abraham D, Bou-Gharios G, de Crombrugghe B (May 2010). "Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis". Arthritis Rheum. 62 (5): 1523–32. doi:10.1002/art.27382. PMC 3866029. PMID 20213804.
  22. ↑ Liu S, Shi-wen X, Abraham DJ, Leask A (January 2011). "CCN2 is required for bleomycin-induced skin fibrosis in mice". Arthritis Rheum. 63 (1): 239–46. doi:10.1002/art.30074. PMID 20936632.
  23. ↑ Ellina O, Chatzigeorgiou A, Kouyanou S, et al. (January 2012). "Extracellular matrix-associated (GAGs, CTGF), angiogenic (VEGF) and inflammatory factors (MCP-1, CD40, IFN-γ) in type 1 diabetes mellitus nephropathy". Clin. Chem. Lab. Med. 50 (1): 167–74. doi:10.1515/cclm.2011.881. PMID 22505539.

External links

Retrieved from "https://www.wikidoc.org/index.php?title=CTGF&oldid=1533133"